The day after completing its latest billion-dollar deal, Boston Scientific dispatched food trucks to hand out fried chicken ...

Following its acquisition of Silk Road in September, Boston Scientific said it plans to consolidate the company’s work in ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

William Plovanic has given his Buy rating due to a combination of factors, including the recent acquisition of Silk Road Medical by Boston Scientific. The acquisition, which closed at an ...

Boston Scientific's strong history, margins, and pipeline make it a buy despite other analysts' Hold rating, with 15% growth ...

Canaccord Genuity maintained a Buy rating on Boston Scientific (NYSE:BSX) and increased the stock's price target to $98 from $88. The adjustment follows the successful acquisition of Silk Road ...

Expanding its portfolio further into cardiovascular health, Marlborough medical device manufacturer Boston Scientific has ...

Marlborough-based Boston Scientific increased its estimated net sales growth for 2024. Meanwhile, Thermo Fisher slightly raised its full-year adjusted earnings per share guidance. Boston ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

Boston Scientific will close Silk Road Medical’s headquarters in Sunnyvale, California, after it bought the maker of stroke prevention products in September. Spokesperson Chanel Hastings wrote ...